← FDA Drug Approvals (Drugs@FDA)

REDITREX

NDA · New Drug Application · Sponsor: NORDIC GRP · Approved 2019-11-27

Drug application

FDA Application #

NDA210737

Application type

New Drug Application

Brand name

REDITREX

Generic name

Methotrexate

Active ingredients

METHOTREXATE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

NORDIC GRP

First approval

2019-11-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown